

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cell communication by electrical coupling (GO:0010649) | 4.10773794 |
| 2 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.03681441 |
| 3 | NADH metabolic process (GO:0006734) | 3.91573515 |
| 4 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.64652453 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.62712326 |
| 6 | regulation of female receptivity (GO:0045924) | 3.61914436 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 3.48537865 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.45666967 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43719427 |
| 10 | regulation of guanylate cyclase activity (GO:0031282) | 3.42606344 |
| 11 | regulation of relaxation of muscle (GO:1901077) | 3.40445476 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.38471212 |
| 13 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.33282576 |
| 14 | detection of calcium ion (GO:0005513) | 3.27114299 |
| 15 | carnitine shuttle (GO:0006853) | 3.18559952 |
| 16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.15720684 |
| 17 | drug catabolic process (GO:0042737) | 3.15374696 |
| 18 | regulation of lipoprotein metabolic process (GO:0050746) | 3.13909729 |
| 19 | female mating behavior (GO:0060180) | 3.13007016 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.12390132 |
| 21 | actin-myosin filament sliding (GO:0033275) | 3.11996727 |
| 22 | muscle filament sliding (GO:0030049) | 3.11996727 |
| 23 | regulation of oxidative phosphorylation (GO:0002082) | 3.09955981 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.09526628 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 3.09526628 |
| 26 | fatty acid transmembrane transport (GO:1902001) | 3.06532308 |
| 27 | sleep (GO:0030431) | 2.97386251 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.95907581 |
| 29 | L-phenylalanine metabolic process (GO:0006558) | 2.95907581 |
| 30 | cGMP-mediated signaling (GO:0019934) | 2.95880598 |
| 31 | negative regulation of protein localization to cell surface (GO:2000009) | 2.95155528 |
| 32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.94776935 |
| 33 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.93265081 |
| 34 | intestinal absorption (GO:0050892) | 2.92353931 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 2.89633327 |
| 36 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.89582907 |
| 37 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.89508802 |
| 38 | relaxation of cardiac muscle (GO:0055119) | 2.88941273 |
| 39 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.86680661 |
| 40 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.86680661 |
| 41 | regulation of skeletal muscle contraction (GO:0014819) | 2.85313357 |
| 42 | creatine metabolic process (GO:0006600) | 2.83041682 |
| 43 | actin-mediated cell contraction (GO:0070252) | 2.81907184 |
| 44 | striated muscle hypertrophy (GO:0014897) | 2.81026981 |
| 45 | cardiac conduction (GO:0061337) | 2.78673663 |
| 46 | exogenous drug catabolic process (GO:0042738) | 2.77833041 |
| 47 | cardiac muscle contraction (GO:0060048) | 2.77576281 |
| 48 | skeletal muscle contraction (GO:0003009) | 2.73261735 |
| 49 | striated muscle contraction (GO:0006941) | 2.72550430 |
| 50 | acylglycerol homeostasis (GO:0055090) | 2.72354647 |
| 51 | triglyceride homeostasis (GO:0070328) | 2.72354647 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 2.72326344 |
| 53 | transcytosis (GO:0045056) | 2.71427104 |
| 54 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.70698465 |
| 55 | muscle hypertrophy in response to stress (GO:0003299) | 2.70698465 |
| 56 | cardiac muscle adaptation (GO:0014887) | 2.70698465 |
| 57 | ethanol oxidation (GO:0006069) | 2.69375144 |
| 58 | relaxation of muscle (GO:0090075) | 2.67476032 |
| 59 | regulation of sequestering of triglyceride (GO:0010889) | 2.67337974 |
| 60 | negative regulation of heart rate (GO:0010459) | 2.66652731 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 2.62846617 |
| 62 | positive regulation of glycolytic process (GO:0045821) | 2.62492803 |
| 63 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.61878400 |
| 64 | blood coagulation, intrinsic pathway (GO:0007597) | 2.61400166 |
| 65 | respiratory electron transport chain (GO:0022904) | 2.56598885 |
| 66 | fatty acid homeostasis (GO:0055089) | 2.55110061 |
| 67 | electron transport chain (GO:0022900) | 2.54516706 |
| 68 | regulation of cGMP biosynthetic process (GO:0030826) | 2.53721704 |
| 69 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.52081493 |
| 70 | vitamin transmembrane transport (GO:0035461) | 2.51252856 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.51233935 |
| 72 | regulation of actin filament-based movement (GO:1903115) | 2.50858181 |
| 73 | myofibril assembly (GO:0030239) | 2.50261918 |
| 74 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.48154676 |
| 75 | drug metabolic process (GO:0017144) | 2.41322410 |
| 76 | oxaloacetate metabolic process (GO:0006107) | 2.41003183 |
| 77 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.40604835 |
| 78 | cardiac muscle cell action potential (GO:0086001) | 2.37849124 |
| 79 | amino-acid betaine transport (GO:0015838) | 2.37444487 |
| 80 | carnitine transport (GO:0015879) | 2.37444487 |
| 81 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.37305921 |
| 82 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.37305921 |
| 83 | cell communication involved in cardiac conduction (GO:0086065) | 2.36757906 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.36060519 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.36060519 |
| 86 | cellular glucuronidation (GO:0052695) | 2.35959108 |
| 87 | flavonoid metabolic process (GO:0009812) | 2.35904747 |
| 88 | regulation of membrane repolarization (GO:0060306) | 2.34674207 |
| 89 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.34349563 |
| 90 | positive regulation of sodium ion transport (GO:0010765) | 2.34277497 |
| 91 | muscle hypertrophy (GO:0014896) | 2.33106377 |
| 92 | carnitine transmembrane transport (GO:1902603) | 2.30619483 |
| 93 | regulation of energy homeostasis (GO:2000505) | 2.29885818 |
| 94 | angiotensin maturation (GO:0002003) | 2.29126835 |
| 95 | cell communication by electrical coupling (GO:0010644) | 2.28070168 |
| 96 | regulation of striated muscle contraction (GO:0006942) | 2.27980121 |
| 97 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.26593524 |
| 98 | cGMP metabolic process (GO:0046068) | 2.24346272 |
| 99 | striated muscle adaptation (GO:0014888) | 2.23656933 |
| 100 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.23572482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.71892834 |
| 2 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.68750229 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.16908337 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.08817973 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08797726 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94581422 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90666054 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86402350 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85252829 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83009502 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79425043 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78563301 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.75247127 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.67285667 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61166807 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59264749 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.58188871 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57906983 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53044279 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49530534 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.48053017 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45483354 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42415349 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.37186722 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35206585 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34986737 |
| 27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.32769150 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31403667 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30807504 |
| 30 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.30437412 |
| 31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30255775 |
| 32 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.30241143 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29603512 |
| 34 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.28916646 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28728862 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26659592 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24332152 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15381684 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13844619 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13350650 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13328568 |
| 42 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11851204 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09667266 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08432379 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07933142 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07907444 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06190027 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05091631 |
| 49 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04210592 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02146121 |
| 51 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02089680 |
| 52 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01081175 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99119717 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97968406 |
| 55 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97874647 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97741566 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97505079 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97243221 |
| 59 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97243221 |
| 60 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.97108505 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96761200 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96656030 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96656030 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.96201217 |
| 65 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96197560 |
| 66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94905761 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94304750 |
| 68 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93781870 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93500078 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93491461 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93461413 |
| 72 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93457708 |
| 73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93285437 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93084812 |
| 75 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.92897128 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92755525 |
| 77 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92418316 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91717355 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91590653 |
| 80 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.91455016 |
| 81 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91409318 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91346346 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89440536 |
| 84 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.89339999 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88943341 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88335637 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88300688 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87237130 |
| 89 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86687572 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86669541 |
| 91 | NFYB_21822215_ChIP-Seq_K562_Human | 0.85328367 |
| 92 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84593293 |
| 93 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84549450 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83157313 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81478811 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.81451864 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81394853 |
| 98 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81309042 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81302196 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80896355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.55369901 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.09184469 |
| 3 | MP0004215_abnormal_myocardial_fiber | 3.03434629 |
| 4 | MP0005670_abnormal_white_adipose | 3.03329561 |
| 5 | MP0004036_abnormal_muscle_relaxation | 2.66205774 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.49495889 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.48256223 |
| 8 | MP0005365_abnormal_bile_salt | 2.46460325 |
| 9 | MP0000751_myopathy | 2.46422817 |
| 10 | MP0004043_abnormal_pH_regulation | 2.43667208 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.37166738 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.34164190 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.32388194 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.22230775 |
| 15 | MP0004130_abnormal_muscle_cell | 2.08938466 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.04940038 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.98606014 |
| 18 | MP0003646_muscle_fatigue | 1.96494790 |
| 19 | MP0008872_abnormal_physiological_respon | 1.95150525 |
| 20 | MP0003879_abnormal_hair_cell | 1.95086347 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.90857493 |
| 22 | MP0006138_congestive_heart_failure | 1.88037062 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.87178580 |
| 24 | MP0004484_altered_response_of | 1.86537559 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.80009076 |
| 26 | MP0003195_calcinosis | 1.78649776 |
| 27 | MP0002972_abnormal_cardiac_muscle | 1.72575472 |
| 28 | MP0001544_abnormal_cardiovascular_syste | 1.70589648 |
| 29 | MP0005385_cardiovascular_system_phenoty | 1.70589648 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.69997029 |
| 31 | MP0005535_abnormal_body_temperature | 1.68192982 |
| 32 | MP0005332_abnormal_amino_acid | 1.63905248 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.63134012 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62372741 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.61355531 |
| 36 | MP0005330_cardiomyopathy | 1.59954315 |
| 37 | MP0008004_abnormal_stomach_pH | 1.58720331 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.58246006 |
| 39 | MP0004859_abnormal_synaptic_plasticity | 1.55571705 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.51380612 |
| 41 | MP0004510_myositis | 1.50236288 |
| 42 | MP0000230_abnormal_systemic_arterial | 1.48515426 |
| 43 | MP0004085_abnormal_heartbeat | 1.45177278 |
| 44 | MP0004270_analgesia | 1.40028261 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.40021883 |
| 46 | MP0003137_abnormal_impulse_conducting | 1.36372282 |
| 47 | MP0001765_abnormal_ion_homeostasis | 1.33809950 |
| 48 | MP0009745_abnormal_behavioral_response | 1.32856349 |
| 49 | MP0009840_abnormal_foam_cell | 1.30887338 |
| 50 | MP0002971_abnormal_brown_adipose | 1.29527364 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.28048596 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.27262510 |
| 53 | MP0001664_abnormal_digestion | 1.26247202 |
| 54 | MP0004087_abnormal_muscle_fiber | 1.22423432 |
| 55 | MP0002064_seizures | 1.21351422 |
| 56 | MP0002272_abnormal_nervous_system | 1.21153627 |
| 57 | MP0001486_abnormal_startle_reflex | 1.17852263 |
| 58 | MP0005409_darkened_coat_color | 1.17126353 |
| 59 | MP0005166_decreased_susceptibility_to | 1.16994216 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.15453860 |
| 61 | MP0003868_abnormal_feces_composition | 1.14829017 |
| 62 | MP0005448_abnormal_energy_balance | 1.13936159 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.13052965 |
| 64 | MP0004885_abnormal_endolymph | 1.10722244 |
| 65 | MP0001440_abnormal_grooming_behavior | 1.10408978 |
| 66 | MP0005369_muscle_phenotype | 1.10350977 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.08623453 |
| 68 | MP0002127_abnormal_cardiovascular_syste | 1.06528916 |
| 69 | MP0000749_muscle_degeneration | 1.04841414 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.04304192 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 1.02710921 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.00156268 |
| 73 | MP0010155_abnormal_intestine_physiology | 0.97400556 |
| 74 | MP0005451_abnormal_body_composition | 0.96550890 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.96041179 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.95715742 |
| 77 | MP0001756_abnormal_urination | 0.94365662 |
| 78 | MP0003252_abnormal_bile_duct | 0.93292364 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.93137668 |
| 80 | MP0008569_lethality_at_weaning | 0.91794441 |
| 81 | MP0005083_abnormal_biliary_tract | 0.91256997 |
| 82 | MP0009046_muscle_twitch | 0.90098454 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.89222694 |
| 84 | MP0003724_increased_susceptibility_to | 0.88636092 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.88231977 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.88033223 |
| 87 | MP0002733_abnormal_thermal_nociception | 0.87914277 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.85212822 |
| 89 | MP0003828_pulmonary_edema | 0.84773845 |
| 90 | MP0000747_muscle_weakness | 0.83565941 |
| 91 | MP0005165_increased_susceptibility_to | 0.83435442 |
| 92 | MP0001764_abnormal_homeostasis | 0.81674709 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.80740040 |
| 94 | MP0001968_abnormal_touch/_nociception | 0.80301641 |
| 95 | MP0002572_abnormal_emotion/affect_behav | 0.80150490 |
| 96 | MP0003866_abnormal_defecation | 0.79591445 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.79031268 |
| 98 | MP0004147_increased_porphyrin_level | 0.78595963 |
| 99 | MP0009115_abnormal_fat_cell | 0.77512314 |
| 100 | MP0001970_abnormal_pain_threshold | 0.77090964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bundle branch block (HP:0011710) | 4.85082577 |
| 2 | Nemaline bodies (HP:0003798) | 4.18100115 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 4.10270895 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.91663456 |
| 5 | Muscle fiber splitting (HP:0003555) | 3.65991119 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61247608 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.60509560 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 3.53951944 |
| 9 | Decreased circulating renin level (HP:0003351) | 3.53116178 |
| 10 | Ventricular fibrillation (HP:0001663) | 3.50531990 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.50008163 |
| 12 | Heart block (HP:0012722) | 3.48761101 |
| 13 | Sudden death (HP:0001699) | 3.44480755 |
| 14 | Syncope (HP:0001279) | 3.39496482 |
| 15 | Hydroxyprolinuria (HP:0003080) | 3.19172567 |
| 16 | Abnormality of proline metabolism (HP:0010907) | 3.19172567 |
| 17 | Abnormal atrioventricular conduction (HP:0005150) | 3.12953858 |
| 18 | Petechiae (HP:0000967) | 3.09855169 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.08162780 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 2.95012321 |
| 21 | Exercise-induced myalgia (HP:0003738) | 2.91904649 |
| 22 | Ventricular arrhythmia (HP:0004308) | 2.88077192 |
| 23 | Atrial fibrillation (HP:0005110) | 2.85049973 |
| 24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.77747805 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.71234806 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 2.67807693 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 2.67596832 |
| 28 | Menorrhagia (HP:0000132) | 2.65907849 |
| 29 | Febrile seizures (HP:0002373) | 2.65257103 |
| 30 | Primary atrial arrhythmia (HP:0001692) | 2.61633022 |
| 31 | Xanthomatosis (HP:0000991) | 2.59891355 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 2.59395966 |
| 33 | Metabolic alkalosis (HP:0200114) | 2.54446600 |
| 34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.54293886 |
| 35 | Ventricular tachycardia (HP:0004756) | 2.54220239 |
| 36 | Type 1 muscle fiber predominance (HP:0003803) | 2.50161875 |
| 37 | Palpitations (HP:0001962) | 2.49354975 |
| 38 | Supraventricular tachycardia (HP:0004755) | 2.48012328 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 2.46156136 |
| 40 | Myoglobinuria (HP:0002913) | 2.39993389 |
| 41 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.39841577 |
| 42 | Hyperglycemia (HP:0003074) | 2.36276482 |
| 43 | Late onset (HP:0003584) | 2.35574150 |
| 44 | Atrioventricular block (HP:0001678) | 2.35220730 |
| 45 | Hyperkalemia (HP:0002153) | 2.34919917 |
| 46 | Supraventricular arrhythmia (HP:0005115) | 2.34673917 |
| 47 | Neck muscle weakness (HP:0000467) | 2.29938054 |
| 48 | Purpura (HP:0000979) | 2.29902705 |
| 49 | Increased circulating renin level (HP:0000848) | 2.29302366 |
| 50 | Hypoglycemic seizures (HP:0002173) | 2.24810608 |
| 51 | Hyperglycinuria (HP:0003108) | 2.22201814 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 2.18736251 |
| 53 | Glycosuria (HP:0003076) | 2.18736251 |
| 54 | Prolonged partial thromboplastin time (HP:0003645) | 2.17279799 |
| 55 | Malnutrition (HP:0004395) | 2.16730998 |
| 56 | Abnormal EKG (HP:0003115) | 2.14229300 |
| 57 | EMG: neuropathic changes (HP:0003445) | 2.13772031 |
| 58 | Acanthocytosis (HP:0001927) | 2.08965134 |
| 59 | Subaortic stenosis (HP:0001682) | 2.08905814 |
| 60 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.08905814 |
| 61 | Exercise-induced muscle cramps (HP:0003710) | 2.08256395 |
| 62 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.06845023 |
| 63 | Poikilocytosis (HP:0004447) | 2.05797964 |
| 64 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05758893 |
| 65 | Tongue fasciculations (HP:0001308) | 2.05167407 |
| 66 | Dilated cardiomyopathy (HP:0001644) | 2.04292025 |
| 67 | Lipoatrophy (HP:0100578) | 2.04123985 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.03966177 |
| 69 | Renal cortical cysts (HP:0000803) | 2.01260147 |
| 70 | Obstructive sleep apnea (HP:0002870) | 2.00610418 |
| 71 | Abnormality of the calf musculature (HP:0001430) | 1.98756583 |
| 72 | Prolonged QT interval (HP:0001657) | 1.98170424 |
| 73 | Pigmentary retinal degeneration (HP:0001146) | 1.96320390 |
| 74 | Complement deficiency (HP:0004431) | 1.96309472 |
| 75 | Ketoacidosis (HP:0001993) | 1.96136555 |
| 76 | Abnormality of potassium homeostasis (HP:0011042) | 1.95990401 |
| 77 | Action tremor (HP:0002345) | 1.94520144 |
| 78 | Areflexia of lower limbs (HP:0002522) | 1.93714409 |
| 79 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.92634037 |
| 80 | Abnormality of lateral ventricle (HP:0030047) | 1.92621764 |
| 81 | Delayed CNS myelination (HP:0002188) | 1.90148102 |
| 82 | Symptomatic seizures (HP:0011145) | 1.90126285 |
| 83 | Generalized aminoaciduria (HP:0002909) | 1.89823624 |
| 84 | Nausea (HP:0002018) | 1.89331757 |
| 85 | Myopathic facies (HP:0002058) | 1.88599089 |
| 86 | Metaphyseal dysplasia (HP:0100255) | 1.88569439 |
| 87 | Confusion (HP:0001289) | 1.87516152 |
| 88 | Epistaxis (HP:0000421) | 1.85453932 |
| 89 | Abnormal pupillary function (HP:0007686) | 1.85386683 |
| 90 | Abnormality of vitamin B metabolism (HP:0004340) | 1.82459799 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 1.82415780 |
| 92 | Clumsiness (HP:0002312) | 1.82019610 |
| 93 | Alkalosis (HP:0001948) | 1.81845929 |
| 94 | Joint hemorrhage (HP:0005261) | 1.81568317 |
| 95 | Hyperphosphatemia (HP:0002905) | 1.80710609 |
| 96 | Rhabdomyolysis (HP:0003201) | 1.78736794 |
| 97 | Diplopia (HP:0000651) | 1.78408373 |
| 98 | Abnormality of binocular vision (HP:0011514) | 1.78408373 |
| 99 | Hypokalemia (HP:0002900) | 1.78215020 |
| 100 | Difficulty running (HP:0009046) | 1.78188513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 4.23377838 |
| 2 | MST4 | 3.44459865 |
| 3 | FRK | 3.05681990 |
| 4 | RIPK4 | 2.92439858 |
| 5 | TAOK3 | 2.87558505 |
| 6 | ACVR1B | 2.80648924 |
| 7 | OBSCN | 2.71328496 |
| 8 | NTRK3 | 2.67635504 |
| 9 | PHKG1 | 2.64133110 |
| 10 | PHKG2 | 2.64133110 |
| 11 | DAPK2 | 2.51999366 |
| 12 | PINK1 | 2.29002278 |
| 13 | RIPK1 | 2.21377918 |
| 14 | TNIK | 1.99107906 |
| 15 | AKT3 | 1.92282585 |
| 16 | MAPK12 | 1.70664315 |
| 17 | STK24 | 1.61774216 |
| 18 | GRK1 | 1.59696338 |
| 19 | MST1R | 1.53594356 |
| 20 | PAK3 | 1.50038182 |
| 21 | MAP3K7 | 1.49632383 |
| 22 | DMPK | 1.49625102 |
| 23 | MAPKAPK3 | 1.43582925 |
| 24 | OXSR1 | 1.42723179 |
| 25 | GRK5 | 1.36651757 |
| 26 | TEC | 1.35739024 |
| 27 | MAP3K13 | 1.26515544 |
| 28 | PTK2B | 1.24499969 |
| 29 | EPHA2 | 1.22397535 |
| 30 | EPHA4 | 1.19083243 |
| 31 | PIK3CA | 1.19032143 |
| 32 | MAP2K6 | 1.18014497 |
| 33 | PRKAA2 | 1.16697703 |
| 34 | STK39 | 1.14836567 |
| 35 | BMX | 1.10650891 |
| 36 | BMPR1B | 1.06911467 |
| 37 | MET | 1.06048462 |
| 38 | MAPK7 | 1.05382237 |
| 39 | CAMK1 | 1.05184573 |
| 40 | TRPM7 | 1.03796912 |
| 41 | MAP3K2 | 1.02620774 |
| 42 | BMPR2 | 1.02596603 |
| 43 | TNK2 | 0.99352762 |
| 44 | TTN | 0.99061457 |
| 45 | ZAP70 | 0.97056536 |
| 46 | DAPK1 | 0.95962813 |
| 47 | WNK4 | 0.93461676 |
| 48 | NME1 | 0.91725240 |
| 49 | ADRBK2 | 0.90808913 |
| 50 | CAMK2A | 0.90729274 |
| 51 | CDC42BPA | 0.90717966 |
| 52 | MAP3K12 | 0.89181132 |
| 53 | MAPK15 | 0.87039452 |
| 54 | MAP2K1 | 0.86294021 |
| 55 | PIK3CG | 0.84260816 |
| 56 | NLK | 0.84149823 |
| 57 | CAMK2D | 0.82172470 |
| 58 | TXK | 0.81656588 |
| 59 | CAMK2G | 0.74305044 |
| 60 | PDK1 | 0.71297200 |
| 61 | ITK | 0.70997403 |
| 62 | PRKG2 | 0.69972740 |
| 63 | STK3 | 0.69773155 |
| 64 | PRKD1 | 0.67430728 |
| 65 | PRKG1 | 0.66806796 |
| 66 | SYK | 0.66058329 |
| 67 | CAMK2B | 0.64120054 |
| 68 | PRKCE | 0.64108392 |
| 69 | PRKAA1 | 0.63564285 |
| 70 | PDPK1 | 0.62432359 |
| 71 | ERBB2 | 0.56708652 |
| 72 | PRKACG | 0.55851859 |
| 73 | SGK1 | 0.54335181 |
| 74 | HIPK2 | 0.53371512 |
| 75 | STK38 | 0.52782283 |
| 76 | PRKCA | 0.52058058 |
| 77 | PKN1 | 0.50945935 |
| 78 | ROCK1 | 0.50290518 |
| 79 | ERN1 | 0.48574850 |
| 80 | PRKCG | 0.48411339 |
| 81 | MAP3K1 | 0.45205102 |
| 82 | PRKACA | 0.44152085 |
| 83 | BLK | 0.43494208 |
| 84 | CDK12 | 0.40194806 |
| 85 | MUSK | 0.39917760 |
| 86 | RPS6KA3 | 0.39502310 |
| 87 | MAP3K3 | 0.38981074 |
| 88 | CAMKK1 | 0.38624251 |
| 89 | CDK19 | 0.36484940 |
| 90 | PDK2 | 0.36141220 |
| 91 | TIE1 | 0.36118770 |
| 92 | IGF1R | 0.35885688 |
| 93 | STK38L | 0.34807269 |
| 94 | FGFR3 | 0.34371018 |
| 95 | PRKCQ | 0.33475270 |
| 96 | PTK2 | 0.32744165 |
| 97 | MAPK11 | 0.32487956 |
| 98 | ADRBK1 | 0.32184727 |
| 99 | CAMK4 | 0.32113233 |
| 100 | DAPK3 | 0.32074644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27563790 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.19049361 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11430770 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.08721594 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.05970538 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99879068 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 1.99344015 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.88506968 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86985135 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.84836717 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.79256098 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.76607446 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73522979 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67701557 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.62430426 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61823169 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61634874 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56064290 |
| 19 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.56018155 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.53715935 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48229853 |
| 22 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.45658391 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.43951419 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43178284 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.42265790 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41570370 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.40450195 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39322597 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.38540195 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35891871 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.32773675 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28358400 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26536819 |
| 34 | Mineral absorption_Homo sapiens_hsa04978 | 1.26102279 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.26058515 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25111501 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23284003 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21329791 |
| 39 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20824771 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15537901 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14554357 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13097765 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12986772 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10046513 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.09607885 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.08838365 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.06890533 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04006647 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03502778 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02151507 |
| 51 | Morphine addiction_Homo sapiens_hsa05032 | 1.00648735 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 1.00296421 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99571663 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95369451 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95341959 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94647434 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92747754 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89974856 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89969656 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88448799 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87372696 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87321088 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85163026 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.84888796 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83968355 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83857363 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83129833 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.80990634 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.80319782 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76655272 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.75489740 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.73311481 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72900753 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72345895 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72047059 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69668856 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68395922 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68057549 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67082100 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66186245 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63297654 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.63093213 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62756981 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61919092 |
| 85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60888074 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60162338 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59855716 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59364871 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.58541321 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58123804 |
| 91 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57450720 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56832798 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56768227 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56536243 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56423374 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50231747 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49197343 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47841773 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47650685 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46933903 |

